retatrutide phase 2 trial type 2 diabetes weight loss 2024 Retatrutide: A Promising Option for Non-Diabetic in Clinical Trials More data on Retatrutide dropped – retatrutide phase 2 trial type

Search (SciFinder database) 910463-68-2 Sequence search (Lens database) HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG Sequence search (NCBI Blast database) HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG Sequence search (SureChEMBL) HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG Mounjaro and Zepbound (tirzepatide) Keyword search ((+TIRZEPATID+ OR MOUNJARO+ OR ZEPBOUND+ OR LY3298176+ OR L__Y3298176 OR (LY 2W 3298176) OR (2023788__19__2) OR (2023788 2W 19 2W 2) OR TWINCRETIN OR GIP/GLP-1 RA OR GIP__GLP___1___RA OR (GIP 2W GLP 2W 1 2W RA) OR (DUAL__GIP__ GLP__1__AGONIST?) OR (DUAL 2W GIP 2W GLP 2W 1 2W AGONIST?) OR +YXEGTFTSDYSIXLDKIAQKAFVQWLIAGGPSSGAPPPS+) Broad drug category Keyword search (((GLUCAGON__LIKE__PEPTIDE__1) OR (GLUCAGON 3W LIKE 3W PEPTIDE 3W 1) OR (GLP__1) OR (GLP 3W 1) OR GLP__1RA OR (GLP 2W 1RA) OR GLP__1R+ OR GLP1 OR (GLUCOSE__DEPENDENT__INSULINOTROPIC__POLYPEPTIDE+) OR (GLUCOSE 2W DEPENDENT 2W INSULINOTROPIC 2W POLYPEPTIDE+) OR (GASTRIC__INHIBITORY__POLYPEPTIDE+) OR (GASTRIC 2W INHIBITORY 2W POLYPEPTIDE+) OR GIP OR GIPR OR GIP_R OR GIP_R

doi: 10.1093/ajcn/nqz285 12

[1] The mechanism likely involves the extract traveling down the gastrointestinal tract as a high-concentration bolus, triggering hormones along the way

To effectively treat MASH, the drug should address the three key issues associated with these conditions: fat accumulation, inflammation, and fibrosis

This may be due to that a downregulation of IGF-1R is necessary to produce a complete inhibition of its function

The Effect of a Future-Self Avatar mHealth Intervention on Physical Activity and Food Purchases: The FutureMe Randomized Controlled Trial